Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,700
Closed -$315K 3253
2017
Q3
$315K Sell
2,700
-1,300
-33% -$164K ﹤0.01% 2390
2017
Q2
$504K Buy
+4,000
New +$509K ﹤0.01% 2324
2017
Q1
Sell
-2,000
Closed -$201K 3078
2016
Q4
$201K Buy
+2,000
New +$195K ﹤0.01% 2920
2016
Q3
Sell
-10,500
Closed -$840K 3219
2016
Q2
$840K Buy
+10,500
New +$815K ﹤0.01% 1879

Other funds holding INCY

John Overdeck's INCY Position: Q2 2026 in Review

John Overdeck increased its Incyte (INCY) stake by 382% in Q2 2026, buying an estimated $157M and bringing the position to 2,003,559 shares worth $227M. The position accounts for 0.16% of the portfolio, ranked #131.

John Overdeck first reported a position in INCY in Q2 2013 and has held it in 49 quarters since. 853 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • John Overdeck held 2,003,559 shares of Incyte worth $227M as of Q2 2026.
  • John Overdeck bought 1,587,645 Incyte shares in Q2 2026, an estimated $157M.
  • Incyte made up 0.16% of John Overdeck's portfolio in Q2 2026, its #131 holding.
  • John Overdeck first reported a position in Incyte in Q2 2013 and has held it in 49 quarters since.
  • 853 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.